House Publications
The Debates are the report—transcribed, edited, and corrected—of what is said in the House. The Journals are the official record of the decisions and other transactions of the House. The Order Paper and Notice Paper contains the listing of all items that may be brought forward on a particular sitting day, and notices for upcoming items.
For an advanced search, use Publication Search tool.
If you have any questions or comments regarding the accessibility of this publication, please contact us at accessible@parl.gc.ca.
|
|
|
Notice PaperNo. 147 Tuesday, December 13, 2022 10:00 a.m. |
|
|
|
|
Introduction of Government Bills |
|
Introduction of Private Members' Bills |
|
Notices of Motions (Routine Proceedings) |
|
Questions |
|
| Q-11062 — December 12, 2022 — Mr. Carrie (Oshawa) — With regard to the clinical trials conducted on COVID-19 vaccine safety, specifically those pertaining to the widely distributed vaccines by Pfizer/BioNTech and Moderna that Health Canada reviewed: (a) were objections raised by the government when these vaccines were allowed to be given to the relatively healthy, unvaccinated trial participants mid-way into Phase 3 of the placebo-controlled clinical trials; (b) if no action was taken in relation to (a), why not; (c) of the safety data that could be analyzed, showing level-1 evidence of vaccine-induced harm (e.g. a risk increase in severe adverse events, more death, and after dissolution of the control group, more deaths in the experimental group), how were they used, if at all, when performing risk-benefit analyses; and (d) what specific information was used by the government to arrive at their position that there was more benefit to administering the COVID-19 vaccines to relatively healthy Canadians than risk? |
| Q-11072 — December 12, 2022 — Mr. Carrie (Oshawa) — With regard to the clinical trials conducted on COVID-19 vaccine effectiveness, specifically those pertaining to the widely distributed vaccines by Pfizer/BioNTech and Moderna that Health Canada reviewed: (a) how many trial participants contracted COVID-19, broken down by participants in the experimental and control groups, versus the total number of participants; (b) why was the information in (a) necessary for ascertaining the absolute risk reduction of acquiring COVID-19 following vaccination, not communicated to the general public to enable a more realistic assessment of health risks in support of informed consent; (c) did any trial protocol deviations occur in trial participants who contracted COVID-19; (d) was the government aware that the clinical trials did not test the ability of the vaccines to stop viral transmission before implementing the federal vaccination policy for government employees, whose stated objectives include the protection of these employees as well as their colleagues and clients from COVID-19; (e) if the answer to (d) is affirmative, what was the justification to mandate relatively healthy government employees to get vaccinated against SARS-CoV-2; (f) who made the decision to implement the policy in (d); and (g) how does the government justify its continued campaigns to encourage vaccination in relatively healthy Canadians, starting as young as 6 months? |
| Q-11082 — December 12, 2022 — Mr. Carrie (Oshawa) — With regard to Health Canada's (HC) approval of the Pfizer COVID-19 mRNA vaccine (BNT162b2): (a) was HC aware that World Health Organization's internationally accepted guidelines for vaccine evaluation, published in 2005 and 2014, are only applicable to traditional vaccines that contain immunogenic substances and adjuvants, and, if not, why not; (b) if the answer to (a) is affirmative, why did HC not require the use of a guidance document applicable to non-traditional COVID-19 mRNA vaccines that are based instead on gene therapy, such as BNT162b2; (c) did the non-clinical pharmacokinetic studies, which also evaluated the biodistribution of the BNT162b2 (V9) lipid nano-particle (LNP) formulation, reported by Pfizer, show extensive off-target biodistribution to major organs in rodents; (d) if the answer to (c) is affirmative, did HC consider the non-clinical biodistribution data to be a major safety concern, and, if not, why not; (e) were clinical pharmacokinetic studies on the biodistribution of the vaccine-encoded spike protein included in the regulatory submission, and, if not, why not; (f) were clinical studies on appropriate biomarkers (e.g. troponin-1 as an indicator for heart damage, C-reactive protein for inflammation) associated with possible vaccine adverse effects related to spike protein in the blood circulation, included in the regulatory submission, and, if not, why not; (g) were clinical studies on the variability of vaccine-generated spike protein concentration between different vaccine recipients for different lots of the COVID-19 mRNA vaccines administered included in the regulatory submission, and, if not, why not; (h) did HC request that relevant genotoxicity and carcinogenicity studies on the vaccine-generated spike protein, as the active component, be included in the regulatory submission, and, if not, why not; (i) why did HC find as acceptable non-clinical studies of vaccine safety using Wistar Han rats; (j) why did HC find as acceptable toxicology studies on the vaccine-generated spike protein that did not also use a non-rodent species; (k) why did HC find as acceptable toxicology studies that did not use a relevant rodent species, such as the Chinese golden hamster, to examine toxic effects of the vaccine-generated spike protein; (l) why did HC not request toxicology studies using Chinese golden hamsters to examine the distribution of vaccine-generated spike protein in the specific tissues of both the mother and the pups to gather information as to whether BNT162b2 is suitable to administer to pregnant women and mothers who are breastfeeding, for more trustworthy clinical data; (m) was HC aware that Table 1 in the Module 5.3.6 Cumulative Analysis of Post-authorization Adverse Event Reports, submitted by Pfizer, states that there were 1,223 deaths over a 3-month period, from December 1, 2020 to February 28, 2021; (n) if the answer to (m) is affirmative, why did HC not recommend that COVID-19 mRNA vaccines be immediately taken off the market on the basis of the high mortality rate following drug administration; (o) has HC investigated the flaws in the documentation of Pfizer's regulated study, as shown in Table 1 of the aforementioned report, which classified the case outcomes of 9,400 people as "unknown," and which indicated that the age of 6,876 cases could not be determined, and, if not, why not; (p) how does HC justify its position that there is no special COVID-19 vaccine hazard for humans based on conventional studies of repeat dose toxicity, when not even immune-histochemistry staining for the vaccine-encoded spike protein was performed with any relevant species; and (q) how does HC view the real-world effectiveness of the COVID-19 mRNA vaccines in reducing viral transmission, when considering peer-reviewed studies that document similar peak loads of viable SARS-CoV-2 virus in the upper airway of fully vaccinated infected individuals and unvaccinated infected individuals, as well as reports of vaccine-induced immune suppression, indicated by reduced production of viral N-protein antibodies following breakthrough infection? |
| Q-11092 — December 12, 2022 — Mr. Blaikie (Elmwood—Transcona) — With regard to the government’s procurement of children’s acetaminophen and ibuprofen in November 2022: did the government purchase any bottles of acetaminophen or ibuprofen directly, with the intention to resell and give those units to retailers, and, if so, what are the details of all contracts, including the (i) total amount paid, (ii) number of units procured, (iii) price per unit, (iv) signatories to the contract? |
| Q-11102 — December 12, 2022 — Mr. Blaikie (Elmwood—Transcona) — With regard to the government’s procurement of children’s acetaminophen and ibuprofen in November 2022: (a) of the units procured by the government, how many are being distributed to (i) for-profit retailers, (ii) non-profits or charitable institutions, (iii) medical clinics and hospitals; (b) what were the total costs incurred by Health Canada to approve the import of foreign supplies of acetaminophen and ibuprofen; and (c) does the government expect reimbursements from for-profit retailers for any costs incurred by the government for acquiring these emergency supplies? |
| Q-11112 — December 12, 2022 — Mr. Blaikie (Elmwood—Transcona) — With regard to Mortgage Loan Insurance for homeowner, small rental, and multi-unit loans offered by the Canada Mortgage and Housing Corporation (CMHC): (a) broken down by type (homeowner, small rental, and multi-unit), mortgage loan insurance product (e.g. CMHC Income Property, Student Housing, etc.), province and territory, and year since 2010, how many mortgage loan insurance policies have been approved for borrowers (i) that own a single property at the time of approval, (ii) that own two properties at the time of approval, (iii) that own three properties at the time of approval, (iv) that own four or more properties at the time of approval, (v) in total; (b) what is the dollar amount of the insured lending for the mortgages in (a); and (c) broken down by year since 2010 and by province and territory, how many homeowner mortgage insurance loans were approved for mortgages on units (i) that are owner occupied without rental income, (ii) that are owner occupied with rental income, (iii) that are non-owner occupied, (iv) in total? |
| Q-11122 — December 12, 2022 — Mr. Seeback (Dufferin—Caledon) — With regard to government measures to stop the importation of goods made using forced Uyghur labour in China, since 2016: (a) how many times have such goods been intercepted or seized at points of entry by the Canada Border Services Agency or the RCMP; and (b) what are the details of each instance in (a), including (i) the date, (ii) the description of goods, including quantity, (iii) the estimated value of the goods, (iv) the point of entry or location, (v) what happened to the intercepted or seized goods, (vi) the charges laid related to the interception or seizure? |
| Q-11132 — December 12, 2022 — Mr. Albas (Central Okanagan—Similkameen—Nicola) — With regard to contracts that were cancelled by the government since January 1, 2019, broken down by department, agency, Crown corporation or other government entity: (a) how many contracts have been cancelled; (b) what is the total amount paid out in cancellation fees or penalties; and (c) what are the details of all such cancellations, including, for each, the (i) date the contract was signed, (ii) date the contract was cancelled, (iii) vendor, (iv) value, (v) description of goods or services, (vi) reason for the cancellation, (vii) cancellation fee or other similar type of cost to the government? |
| Q-11142 — December 12, 2022 — Mrs. Gallant (Renfrew—Nipissing—Pembroke) — With regard to Veterans Affairs Canada (VAC): (a) what specific criteria, metrics, and formulas are used when determining if a VAC employee (i) below the executive level, (ii) at the executive level or higher, receives a performance bonus; (b) what are the details of the scoring or grading system used in relation to determining performance bonuses; (c) what are the various bonus levels and what score or grade is required to obtain each bonus level; (d) for each of the past five fiscal years, what was the number of VAC employees (i) below the executive level, (ii) at the executive level or higher, that received a performance bonus; (e) what dollar amounts are represented by the bonuses in each of the parts in (d); (f) what percentage of VAC employees (i) below the executive level, (ii) at the executive level or higher, received a performance bonus; and (g) how is saving VAC money factored or taken into consideration when determining performance bonuses? |
| Q-11152 — December 12, 2022 — Mr. Falk (Provencher) — With regard to government statistics on the causes of death in Canada: (a) broken down by year, between 2019 and 2022 to date, what are the leading causes for the total population and by age group; and (b) for deaths listed under “other causes of death” by Statistics Canada, what is the breakdown of each cause included as part of that category that was responsible for more than 100 deaths since 2019? |
| Q-11162 — December 12, 2022 — Mrs. Goodridge (Fort McMurray—Cold Lake) — With regard to drug shortages in Canada: (a) what drugs are currently considered in short supply in Canada; (b) for each drug in (a), (i) what is it used for, (ii) when did it become in short supply, (iii) what is the estimate on how long the shortage of the drug will continue, (iv) what is reason for the supply shortage, if known; and (c) of the drugs in (a), which ones are deemed essential? |
| Q-11172 — December 12, 2022 — Ms. Barron (Nanaimo—Ladysmith) — With regard to harmful waste dumping in Marine Protected Areas (MPAs), broken down by MPA and fiscal year since 2015-16: (a) how much harmful waste has been dumped in MPAs, broken down by (i) sewage, (ii) grey water, (iii) bilge water, (iv) scrubber washwater; (b) how many incidents of dumping are known to have taken place within MPAs; (c) for each incident in (b), what types of ships were the discharges from; and (d) for existing MPAs, does the government intend to strengthen the definition of dumping in order to prevent further harmful substances being introduced into Canada’s oceans? |
| Q-11182 — December 12, 2022 — Mr. Johns (Courtenay—Alberni) — With regard to expanding access to safer alternatives to illegal substances: (a) is the government actively developing a national safer supply program; (b) if the answer to (a) is affirmative, (i) what steps have been completed or initiated to date, (ii) what, if any, timelines have been established in relation to this goal; and (c) if the answer to (a) is affirmative, has the mandate of the Expert Advisory Group on Safer Supply been amended to include leading the design of a national safer supply program? |
| Q-11192 — December 12, 2022 — Mr. Johns (Courtenay—Alberni) — With regard to the development of national standards on mental health and substance use services: (a) what steps were taken between the tabling of budget 2021 and March 14, 2022, in relation to this work; (b) what are the deliverables of the Standards Council of Canada (SCC) in relation to this work; (c) what specific standards are being developed by the SCC; (d) what was the planned timeline for the development of these standards and is it anticipated that the timeline will be met; (e) what, if any, public consultations regarding these standards have taken place or been initiated to date; and (f) does the government intend to delay the establishment of the Canada Mental Health Transfer until the development of such standards are complete? |
| Q-11202 — December 12, 2022 — Mr. Motz (Medicine Hat—Cardston—Warner) — With regard to the Order in Council SOR/2020-96, published on May 1, 2020, which states that “the newly prescribed firearms are primarily designed for military or paramilitary purposes”: (a) which specific models that were prohibited on May 1, 2020, and thereafter, have been or are still in use by the Canadian Armed Forces; and (b) for all the specific models prohibited on May 1, 2020 or since then, what were the permitted legal uses of these firearms in Canada prior to their prohibition (i.e. hunting, sport-shooting, collecting), broken down by make and model? |
| Q-11212 — December 12, 2022 — Mr. Johns (Courtenay—Alberni) — With regard to the PocketWell application: (a) has the application been clinically validated, and, if so, how; (b) what were the estimated costs of developing, maintaining, updating, and promoting the application; (c) how much has been spent to date in relation to the application; (d) what is the itemized breakdown of spending to date on developing, maintaining, updating, and promoting the application; (e) what are the details of all contracts signed by the government related to the application, including, for each, (i) the vendor, (ii) the date, (iii) the value, (iv) the start and end dates, if applicable, (v) the description of goods or services provided, (vi) whether the contract was sole-sourced or awarded through a competitive bidding process; (f) how many times has the application been downloaded; (g) what metrics are being tracked regarding usage and performance of the application; (h) since the launch of the application, what were the average daily and monthly users; (i) what measures are in place to protect the personal information and privacy of users; and (j) who owns the intellectual property related to the application? |
| Q-11222 — December 12, 2022 — Mr. Johns (Courtenay—Alberni) — With regard to any polling data obtained by the Privy Council Office or the Treasury Board of Canada Secretariat since March 1, 2020, related to remote or hybrid work by public service workers: what are the details of all such polling, including, for each poll, (i) who conducted the poll, (ii) the start and end dates of when the poll was conducted, (iii) the number of participants, (iv) the complete results of the poll, including the questions asked and the responses received, (v) the value of the contract related to the poll? |
| Q-11232 — December 12, 2022 — Mr. Williams (Bay of Quinte) — With regard to Innovation, Science and Economic Development Canada and the $8,831,029,798 raised by the June 2021 3500Mhz Wireless Spectrum Auction: (a) where are these revenues projected to be spent, broken down by (i) program, (ii) amount; (b) are any of these funds projected to be spent on programs related to expanding internet or wireless connectivity for Canadians; and (c) if the answer to (b) is affirmative, what are the details, broken down by (i) program, (ii) amount, (iii) province, (iv) number of Canadians affected? |
| Q-11242 — December 12, 2022 — Mr. Williams (Bay of Quinte) — With regard to Innovation, Science and Economic Development Canada, since March 2021: (a) have any briefing notes been prepared for the minister or ministerial staff relating to the proposed merger of Rogers Communications and Shaw Communications, and, if so, what are the details, including, for each, the (i) subject, (ii) author, (iii) date prepared, (iv) date delivered, (v) internal department tracking number, (vi) title; and (b) have any briefing notes been prepared for the minister or ministerial staff relating to the proposed sale of Freedom Mobile by Shaw Communications, and, if so, what are the details of each, including, the (i) subject, (ii) author, (iii) date prepared, (iv) date delivered, (v) internal department tracking number, (vi) title? |
| Q-11252 — December 12, 2022 — Mr. Hallan (Calgary Forest Lawn) — With regard to the financing of Canada’s federal government debt: (a) how many government bonds matured in fiscal years 2020-21 and 2021-22, broken down by fiscal year; (b) what is the dollar amount of the maturing bonds in (a), broken down by fiscal year; (c) what is the breakdown by maturity date of the bonds in (a), broken down by fiscal year; (d) how many of the bonds in (a) were repurchased in fiscal year 2020-21; (e) what is the dollar amount of repurchased bonds in (d); (f) what was the interest rate of the bonds in (d); (g) how many of the bonds in (a) were repurchased in fiscal year 2021-22; (h) what is the dollar amount of repurchased bonds in (g); (i) what was the interest rate of the bonds in (g); (j) how many government bonds are maturing in fiscal year 2022-23; (k) what is the breakdown of bonds in (j) by maturity date; (l) how many bonds in (j) are going to be repurchased; (m) what are the maturity dates of the repurchased bonds in fiscal year 2022-23; (n) what is the dollar amount of bonds in (j); (o) what is the estimated dollar amount for repurchasing bonds in (l); (p) what is the interest rate for the bonds that have already been purchased in fiscal year 2022-23; (q) how many government bonds will be maturing in fiscal year 2023-24; (r) what is the breakdown of (p) by maturity date; (s) what is the dollar amount of bonds in (p); and (t) what is the dollar amount of bonds in (q)? |
| Q-11262 — December 12, 2022 — Mr. Desjarlais (Edmonton Griesbach) — With regard to federal government investments in housing, for each fiscal year since 2015-16: (a) what was the total amount of federal funding spent on housing in the city of Edmonton; (b) what was the total amount of federal funding spent on housing in the federal riding of Edmonton Griesbach; (c) how much funding was allocated to each of the following programs and initiatives in the city of Edmonton (i) the Rental Construction Financing initiative, (ii) Proposal Development Funding, (iii) Investment in Affordable Housing, (iv) Affordable Housing Innovation Fund, (v) nonprofit on-reserve funding, (vi) prepayment, (vii) Reno & Retrofit CMHC, (viii) renovation programs on reserve, (ix) retrofit on-reserve and seed funding; (d) how much funding was allocated to each of the following programs and initiatives in the federal riding of Edmonton Griesbach (i) the Rental Construction Financing initiative, (ii) Proposal Development Funding, (iii) Investment in Affordable Housing, (iv) Affordable Housing Innovation Fund, (v) nonprofit on-reserve funding, (vi) prepayment, (vii) Reno & Retrofit CMHC, (viii) renovation programs on-reserve, (ix) retrofit on-reserve and seed funding; (e) how much federal funding was allocated to housing subsidies in the city of Edmonton for (i) nonprofit on-reserve housing, (ii) co-operative housing, (iii) Urban Native Housing, (iv) non-profit housing, (v) index linked, (vi) mortgage co-operatives, (vii) rent geared to income, (viii) and Federal Community Housing Initiative; (f) how much federal funding was allocated to housing subsidies in the federal riding of Edmonton Griesbach for (i) nonprofit on-reserve housing, (ii) co-operative housing, (iii) Urban Native Housing, (iv) nonprofit housing, (v) index linked, (vi) mortgage co-operatives, (vii) rent geared to income, (viii) Federal Community Housing Initiative; (g) what was the total amount of federal housing funding distributed as grants in the city of Edmonton; (h) what was the total amount of federal housing funding distributed as grants in the federal riding of Edmonton Griesbach; (i) what was the total amount of federal housing funding distributed as loans in the city of Edmonton; and (j) what was the total amount of federal housing funding distributed as loans in the federal riding of Edmonton Griesbach? |
| Q-11272 — December 12, 2022 — Mr. Desjarlais (Edmonton Griesbach) — With regard to federal spending in the constituency of Edmonton Griesbach, broken down by fiscal year and department or agency: what are the details of all grants, contributions and all loans to any organization, group, business or municipality, broken down by the (i) name of the recipient, (ii) date the funding was received, (iii) amount received, (iv) program under which the grant, contribution or loan was made? |
| Q-11282 — December 12, 2022 — Ms. Blaney (North Island—Powell River) — With regards to meteorological stations in British Columbia under the responsibility of Environment and Climate Change Canada: (a) what are the details of all stations, including the (i) location, (ii) number of staff employed, (iii) operational status; (b) for each station in (a), what (i) was the last date the station was reviewed for operational maintenance, (ii) plans are underway or scheduled to ensure the station is fully operational? |
| Q-11292 — December 12, 2022 — Ms. Blaney (North Island—Powell River) — With regards to Veterans Affairs Canada service providers, and broken down by province or territory: (a) what is the total number of service providers available to veterans that offer services in (i) English only, (ii) French only, (iii) both official languages, (iv) Indigenous languages; and (b) what is the total number of service providers who offer services in languages not listed in (a), broken down by language? |
| Q-11302 — December 12, 2022 — Ms. Blaney (North Island—Powell River) — With regard to Rural and Suburban Mail Carriers (RSMCs), broken down by province or territory and fiscal year since 2015-16: (a) what is the total number of RSMCs required to use their own vehicles to deliver mail; (b) how many employees were remunerated at (i) the maximum tax-exempt-per allowance rate, (ii) under the maximum tax-exempt-per allowance rate; (c) what was the maximum tax-exempt-per allowance limit and rate for each fiscal year; (d) what was the total amount remunerated to RSMCs under (i) the maximum tax-exempt-per allowance rate, (ii) under the maximum tax-exempt-per allowance rate; and (e) what is the total amount of actual automobile expenses covered for RSMCs? |
| Q-11312 — December 12, 2022 — Mr. McCauley (Edmonton West) — With regard to the Canada Revenue Agency and linkage studies that link citizens who complete the census with tax data: what are the details of all such studies which have taken place since January 1, 2018, including, for each, (i) the date, (ii) the methodology, (iii) the scope, including the number of individuals whose data was linked, (iv) the topics studied, (v) the findings, (vi) who conducted the study? |
| Q-11322 — December 12, 2022 — Mrs. Stubbs (Lakeland) — With regard to the Trans Mountain Expansion Project of the Trans Mountain Corporation, a subsidiary of the Canada Development Investment Corporation, broken down by year from 2018 to present: what is the total amount spent, or allocated to be spent, on persons not employed by the Trans Mountain Corporation or the government engaging in (i) external communications, (ii) internal communications, (iii) liaison activities between any department or ministry of the government and Trans Mountain Corporation, (iv) image consulting or similar type of consulting? |
| Q-11332 — December 12, 2022 — Mrs. Stubbs (Lakeland) — With regard to statistics held by the government related to entities engaging in blending operations of renewable fuel and petroleum fuel in Canada: (a) what are the details of all known blending operations in Canada, including locations; (b) for each blending location, what are the countries of origin of the renewable feedstock; and (c) what percentage of renewable fuel used in Canadian blending operations originated from each country, broken down by year since 2015? |
| Q-11342 — December 12, 2022 — Mr. Desjarlais (Edmonton Griesbach) — With regard to government policies on funding directed towards First Nations, Inuit and Métis people, broken down by department since fiscal year 2015-16: (a) what policies, processes, and protocols exist to validate claims of Indigenous ancestry or Indigenous community; (b) what reviews or audits have been conducted to ensure that government funding has not been delivered to individuals, organizations, or companies that falsely claim an Indigenous identity; (c) is the government aware of any funding that has been allocated to individuals, organizations, or companies that falsely claimed an Indigenous identity; and (d) for each funding allocation in (c), how much funding has been recalled on the basis of false claims of Indigenous identity? |
| Q-11352 — December 12, 2022 — Ms. Lewis (Haldimand—Norfolk) — With regard to the Canada Infrastructure Bank (CIB), since December 1, 2021: (a) what is the total amount of federal funding given to the CIB; (b) what are the details of all infrastructure commitments and investments made by the bank, including, for each project, the (i) name, (ii) location, (iii) description, (iv) date the agreement was signed, (v) total agreed expenditure by the CIB, (vi) total expenditures to date by the CIB, (vii) agreed completion date, (viii) current expected completion date, (ix) the loan’s risk allocation, term and pricing, (x) evaluation results from the Investment Framework process; and (c) what is the amount spent by the CIB on (i) salaries, (ii) bonuses, (iii) consulting fees, (iv) rent or lease payments, (v) travel, (vi) hospitality, (vii) infrastructure programs, (viii) other expenses? |
| Q-11362 — December 12, 2022 — Ms. Lewis (Haldimand—Norfolk) — With regard to the Canada Infrastructure Bank (CIB), since January 1, 2021: (a) what were the costs incurred during the due diligence period for the Lake Erie Connector Project, broken down by category and type of expenditure; (b) what is the summary of the terms of the project agreement with ITC Holdings Corporation; (c) what were the justifications provided to the CIB for the suspension of the Lake Erie Connector Project; (d) on what date was the CIB informed of the Lake Erie Connector Project’s suspension; and (e) on what date was the Minister of Infrastructure or his staff informed of the Lake Erie Connector Project’s suspension? |
| Q-11372 — December 12, 2022 — Ms. Lewis (Haldimand—Norfolk) — With regard to the Canada Infrastructure Bank (CIB) and the five-year review of the Canada Infrastructure Bank Act: (a) what is the status of the government’s five-year review; (b) what are the details of the review plan, including the (i) plan summary, (ii) stakeholders consulted to date and to be consulted, (iii) consultants or experts engaged and to be engaged, (iv) metrics by which the government is assessing the CIB’s performance, (v) formal meetings or initiatives taken place to date, (vi) formal meetings or initiatives scheduled to take place; (c) what plans does the government have to (i) consult the public, (ii) provide the public with details of the review; and (d) to what extent is the government considering the single recommendation of the third report of the Standing Committee on Transport, Infrastructure and Communities in its assessment of the CIB under the Act? |
| Q-11382 — December 12, 2022 — Ms. Lewis (Haldimand—Norfolk) — With regard to the Public Accounts of Canada for 2021 and 2022: (a) what are the details and identified program objectives of the transfer payments made to the World Economic Forum (WEF) by (i) Environment and Climate Change Canada, (ii) Fisheries and Oceans Canada, (iii) Global Affairs Canada; (b) for each transfer payment to the WEF, what (i) is the summary of the terms of the agreement in place, (ii) are the categories and type of cost allocations associated with each transfer payment; (c) what accounting does the government have of how the transfer payments to the WEF are being spent; and (d) if the answer to (c) is none, why is there no accounting? |
| Q-11392 — December 12, 2022 — Ms. McPherson (Edmonton Strathcona) — With regard to the number of Albertans, residing in Alberta, and Canadian or Permanent Residents from other provinces and territories living temporarily in Alberta, who received COVID-related financial support, specifically the Canada Emergency Response Benefit (CERB) and the Employment Insurance Emergency Response Benefit (ERB) (payments issued by both the Canada Revenue Agency (CRA) and by Service Canada), broken down by fiscal year, between April 1, 2020, and May 7, 2022: (a) of the total recipients who did receive CERB/ERB, how many were found by the government to be ineligible for the benefit and were notified that they must repay those funds, broken down by number and percentage of total successful applicants; (b) of the recipients in (a), how many were (i) 25 years or less, (ii) 65 years of age or above; (c) of the total recipients who received CERB/ERB, how many were found by the government to be ineligible to receive the benefit, but whose debt was waived or forgiven; (d) of the recipients in (c), how many were (i) 25 years or less, (ii) 65 years of age or above; (e) of the total recipients who did receive CERB/ERB (i) how many had other CRA or Service Canada issued federal benefits such as the Guaranteed Income Supplement (GIS), the Canada Child Benefit, or the Goods and Services Tax credit, negatively impacted or reduced, in part or in full, (ii) of those CERB recipients 65 years of age or over whose GIS benefit was negatively impacted (or reduced entirely) due to a higher household income resulting from their application for and acceptance of CERB in the preceding calendar year, how many Albertans had their GIS restored in either April 2022 (special measures) or in July 2022 (the start of the 2022-23 benefits calendar), broken down by partial restoration or full restoration? |
| Q-11402 — December 12, 2022 — Ms. McPherson (Edmonton Strathcona) — With regard to funding for Official Development Assistance, since 2019: (a) what is the total amount going to Canadian civil society partners, broken down within Canada by organization and by their province of registry; (b) what is the total amount going to U.S. partners; (c) what is the overall total amount, broken down by organizational size; and (d) what category does the recipient organization in (c) fall into, broken down by (i) civil society, (ii) multi-lateral, (iii) private sector? |
| Q-11412 — December 12, 2022 — Ms. McPherson (Edmonton Strathcona) — With regard to the number of funding applications through international development projects processed by Global Affairs Canada: what percentage of successful, complete applications received by the department were processed within the departments stated delivery standards? |
| Q-11422 — December 12, 2022 — Ms. McPherson (Edmonton Strathcona) — With regard to sanctions imposed by Canada under the United Nations Act, the Special Economic Measures Act and the Justice for Victims of Corrupt Foreign Officials Act, broken down by dollar value: (a) how many individuals have had their assets seized who are associated with sanctions targeting (i) Russia, (ii)Belarus (iii) Russian-influenced Ukrainians; (b) how many more assets are there in Canada that have been identified; (c) since June 23, 2022, how many orders have been issued under (i) section (4)(1)(b) of the Special Economic Measures Act (ii) section (4)(1)(b) of the Justice for Victims of Corrupt Foreign Officials Act; (d) since June 23rd, 2022, how many forfeiture orders have been issued under (i) section 5.4(1) of the Special Economic Measures Act (ii) section 4.2(1) of the Justice for Victims of Corrupt Foreign Officials Act? |
| Q-11432 — December 12, 2022 — Mr. Green (Hamilton Centre) — With regard to the government’s remote work policy, broken down by department and agency: (a) what is the total number of employees who are currently working (i) entirely from home, (ii) in a hybrid format; (b) what is the total number of employees under a formal remote work arrangement; (c) what is the total number of remote work arrangements (i) requested, (ii) approved, (iii) denied; (d) what is the total number of employees fully working in their regular workplace, broken down by classification and level; (e) what is the total number of employees using formal flexible work arrangements, such as flexible hours, compressed hours, or variable hours; (f) what is the total number of flexible work arrangements (i) requested, (ii) approved, (iii) declined? |
| Q-11442 — December 12, 2022 — Mr. Green (Hamilton Centre) — With regard to hiring decisions in federal departments, broken down by department and month that the policy came into effect: (a) how many departments have put in place a policy to freeze or limit staffing actions since January 2022; (b) what is the department’s current policy on staff actions for the departments in (a); and (c) how many departments in (a) were the result of directives or orders issued by a minister or deputy-minister? |
| Q-11452 — December 12, 2022 — Ms. Kwan (Vancouver East) — With regard to the special immigration measures for Afghan nationals: (a) broken down by current country of residence and stream (people who assisted the government of Canada, humanitarian, extended family of former interpreters, and the special program to sponsor Afghan refugees without UNHCR status) and the year of the application, (i) how many applicants have been assigned a unique client identifier number, (ii) how many applicants have been assigned an application number starting with the letter G and are awaiting to come to Canada, (iii) how many applications are awaiting to have their biometrics completed, (iv) how many applications have biometrics completed for all applicants and are awaiting a flight to Canada, (v) how many have satisfied all the requirements such as medical, biometrics, security checks, etc.; (b) what are the average processing times for a successful application; (c) what is the average waiting time for successful applicants to be assigned a flight destined for Canada; (d) how many are still awaiting departure to come to Canada; (e) how many applications have been rejected under the special measures because they do not have a valid visa or expired visa in the third country; (f) how much funding has the government allocated to the International Organization for Migration (IOM); (g) how many IOM housing units are funded by the government of Canada; (h) how many Afghan nationals under the special measures have (i) been assigned to an IOM housing unit, (ii) are waiting for a unit, (iii) are being asked to pay back housing costs; and (i) for Afghan nationals under the special measures being asked to pay back housing costs, (i) how much are they being asked to pay on average, (ii) what is the timeline for repayment? |
Notices of Motions for the Production of Papers |
|
Business of Supply |
|
Government Business |
|
Private Members' Notices of Motions |
|
Private Members' Business |
| C-291 — December 7, 2022 — Mr. Arnold (North Okanagan—Shuswap) — Consideration at report stage of Bill C-291, An Act to amend the Criminal Code and to make consequential amendments to other Acts (child sexual abuse material), as reported by the Standing Committee on Justice and Human Rights with amendments. |
| Pursuant to Standing Order 86(3), jointly seconded by: |
| Mr. Viersen (Peace River—Westlock) — September 16, 2022 |
| Ms. Lewis (Haldimand—Norfolk) — November 14, 2022 |
| Committee report — presented on Wednesday, December 7, 2022, Sessional Paper No. 8510-441-173. |
| Report and third reading stages — limited to two sitting days, pursuant to Standing Order 98(2). |
| Motion for third reading — may be made in the same sitting, pursuant to Standing Order 98(2). |
|
|
|
| 2 Response requested within 45 days |
|